ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
Price:
15.57
CNY
6.06%
Market Closed
Market Cap:
¥6.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
CN |
Income Statement
Earnings Waterfall
ShuYu Civilian Pharmacy Corp Ltd
ShuYu Civilian Pharmacy Corp Ltd
Income Statement
ShuYu Civilian Pharmacy Corp Ltd
ShuYu Civilian Pharmacy Corp Ltd
Currency: CNY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
7
|
10
|
0
|
10
|
32
|
42
|
58
|
75
|
73
|
66
|
79
|
92
|
118
|
121
|
133
|
135
|
139
|
139
|
0
|
0
|
|
| Revenue |
4 640
N/A
|
4 705
+1%
|
4 871
+4%
|
5 018
+3%
|
5 322
+6%
|
5 724
+8%
|
6 232
+9%
|
6 854
+10%
|
7 823
+14%
|
8 308
+6%
|
8 694
+5%
|
9 110
+5%
|
9 191
+1%
|
9 558
+4%
|
9 748
+2%
|
9 735
0%
|
9 570
-2%
|
9 510
-1%
|
9 633
+1%
|
9 938
+3%
|
|
| Gross Profit | |||||||||||||||||||||
| Cost of Revenue |
(3 245)
|
(3 300)
|
(3 433)
|
(3 529)
|
(3 806)
|
(4 079)
|
(4 467)
|
(4 979)
|
(5 592)
|
(5 987)
|
(6 180)
|
(6 451)
|
(6 597)
|
(6 924)
|
(7 152)
|
(7 204)
|
(7 158)
|
(7 166)
|
(7 297)
|
(7 544)
|
|
| Gross Profit |
1 395
N/A
|
1 404
+1%
|
1 438
+2%
|
1 489
+4%
|
1 515
+2%
|
1 645
+9%
|
1 765
+7%
|
1 875
+6%
|
2 231
+19%
|
2 321
+4%
|
2 514
+8%
|
2 659
+6%
|
2 594
-2%
|
2 634
+2%
|
2 596
-1%
|
2 531
-3%
|
2 412
-5%
|
2 344
-3%
|
2 336
0%
|
2 393
+2%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(1 115)
|
(1 079)
|
(1 114)
|
(1 202)
|
(1 340)
|
(1 446)
|
(1 552)
|
(1 649)
|
(1 847)
|
(1 897)
|
(2 038)
|
(2 159)
|
(2 301)
|
(2 392)
|
(2 432)
|
(2 453)
|
(2 446)
|
(2 409)
|
(2 415)
|
(2 454)
|
|
| Selling, General & Administrative |
(1 062)
|
(1 073)
|
(1 123)
|
(1 216)
|
(1 297)
|
(1 466)
|
(1 574)
|
(1 666)
|
(1 794)
|
(1 915)
|
(2 054)
|
(2 178)
|
(2 236)
|
(2 398)
|
(2 432)
|
(2 445)
|
(2 371)
|
(2 371)
|
(2 383)
|
(2 431)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(53)
|
0
|
0
|
0
|
(63)
|
0
|
0
|
0
|
(63)
|
0
|
0
|
0
|
(79)
|
0
|
0
|
0
|
(88)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
(6)
|
9
|
14
|
20
|
21
|
23
|
17
|
10
|
18
|
16
|
18
|
14
|
7
|
(0)
|
(8)
|
13
|
(38)
|
(32)
|
(23)
|
|
| Operating Income |
280
N/A
|
326
+16%
|
324
0%
|
287
-12%
|
175
-39%
|
199
+14%
|
213
+7%
|
226
+6%
|
384
+70%
|
424
+10%
|
476
+12%
|
500
+5%
|
292
-42%
|
242
-17%
|
164
-32%
|
77
-53%
|
(34)
N/A
|
(65)
-92%
|
(79)
-21%
|
(61)
+23%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
0
|
(10)
|
(13)
|
(20)
|
2
|
(6)
|
(18)
|
(33)
|
(62)
|
(88)
|
(110)
|
(121)
|
(101)
|
(125)
|
(121)
|
(123)
|
(118)
|
(126)
|
(125)
|
3
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
(1)
|
2
|
2
|
3
|
3
|
7
|
11
|
14
|
19
|
(26)
|
25
|
28
|
28
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
12
|
9
|
5
|
5
|
(23)
|
(31)
|
(24)
|
(24)
|
(3)
|
5
|
(3)
|
(13)
|
(20)
|
(23)
|
(32)
|
(24)
|
(35)
|
(33)
|
(29)
|
(32)
|
|
| Pre-Tax Income |
293
N/A
|
324
+11%
|
316
-2%
|
272
-14%
|
150
-45%
|
162
+8%
|
171
+5%
|
168
-2%
|
321
+91%
|
343
+7%
|
367
+7%
|
369
+1%
|
178
-52%
|
104
-41%
|
25
-76%
|
(51)
N/A
|
(213)
-317%
|
(199)
+7%
|
(205)
-3%
|
(61)
+70%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
(73)
|
(81)
|
(82)
|
(66)
|
(36)
|
(35)
|
(32)
|
(39)
|
(87)
|
(92)
|
(103)
|
(102)
|
(38)
|
(20)
|
(10)
|
3
|
8
|
4
|
14
|
(14)
|
|
| Income from Continuing Operations |
220
|
243
|
234
|
206
|
114
|
127
|
138
|
129
|
233
|
250
|
264
|
267
|
140
|
85
|
16
|
(48)
|
(205)
|
(194)
|
(191)
|
(76)
|
|
| Income to Minority Interest |
(3)
|
(2)
|
(2)
|
(2)
|
1
|
(0)
|
1
|
6
|
(4)
|
(6)
|
(7)
|
(6)
|
(7)
|
(6)
|
3
|
6
|
16
|
20
|
14
|
9
|
|
| Net Income (Common) |
216
N/A
|
241
+12%
|
233
-4%
|
203
-13%
|
115
-43%
|
127
+10%
|
139
+10%
|
135
-3%
|
229
+70%
|
244
+7%
|
257
+5%
|
261
+2%
|
133
-49%
|
79
-41%
|
18
-77%
|
(42)
N/A
|
(189)
-349%
|
(174)
+8%
|
(177)
-2%
|
(66)
+62%
|
|
| EPS (Diluted) |
0.53
N/A
|
0.6
+13%
|
0.57
-5%
|
0.5
-12%
|
0.28
-44%
|
0.31
+11%
|
0.34
+10%
|
0.33
-3%
|
0.57
+73%
|
0.6
+5%
|
0.63
+5%
|
0.64
+2%
|
0.33
-48%
|
0.2
-39%
|
0.05
-75%
|
-0.1
N/A
|
-0.47
-370%
|
-0.43
+9%
|
-0.44
-2%
|
-0.16
+64%
|
|
Switch to:
Switch to:
See Also
Discover More
